We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1576 for:    REVEAL 2
Previous Study | Return to List | Next Study

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03721978
Recruitment Status : Completed
First Posted : October 26, 2018
Last Update Posted : September 30, 2022
Sponsor:
Information provided by (Responsible Party):
Inovio Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 23, 2022
Actual Study Completion Date : September 14, 2022